Tetracycline and Macrolide Co-Resistance in Streptococcus pyogenes: Co-Selection As a Reason for Increase in Macrolide-Resistant S. pyogenes?
- 1 September 2004
- journal article
- research article
- Published by Mary Ann Liebert Inc in Microbial Drug Resistance
- Vol. 10 (3) , 231-238
- https://doi.org/10.1089/mdr.2004.10.231
Abstract
In Denmark, tetracycline resistance in Streptococcus pyogenes is frequent (>30%) whereas macrolide resistance is low (<5%). The aim of this study was to investigate the genetic background of tetracycline- and macrolide resistance in macrolide-resistant S. pyogenes (MRSP) and to investigate the correlation between the use of macrolide and tetracycline and macrolide resistance using international data. A total of 133 MRSP isolates were received at Statens Serum Institut from nine Danish clinical microbiology laboratories between. November 2000, and November 2002. The macrolide-resistance genes, erm(B), erm(A), and mef(A) were detected in 46%, 18%, and 32% of the tested MRSP isolates, respectively. In 4% of MRSP isolates, none of the MR genes were detected. Tetracycline resistance was found in 52% of MRSP. Tetracycline resistance was encoded by either tet(M) or tet(O). erm(B) and mef(A) were associated with tet(M). Sixteen different T types were detected among the 133 MRSP. Analysis of the importance of antibiotic use for development of macrolide resistance in S. pyogenes showed no correlation with macrolide use alone (p = 0.15) but a significant correlation (p = 0.03) for the combination of macrolide and tetracycline use. The frequency of macrolide resistance in Danish S. pyogenes was low and mainly due to erm genes. A high frequency of macrolide-tetracycline coresistance in S. pyogenes is found in many countries including Denmark, hence tetracycline use must be considered as a co-factor in selection of MRSP.Keywords
This publication has 26 references indexed in Scilit:
- A vancomycin-resistant Enterococcus faecium isolate from a Danish healthy volunteer, detected 7 years after the ban of avoparcin, is possibly related to pig isolatesJournal of Antimicrobial Chemotherapy, 2004
- Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in SpainJournal of Antimicrobial Chemotherapy, 2003
- Comparative in vitro activities of tigecycline (GAR-936) and other antimicrobial agents against Stenotrophomonas maltophilia.Journal of Antimicrobial Chemotherapy, 2002
- Pharmacoepidemiological Analysis of Provincial Differences between Consumption of Macrolides and Rates of Erythromycin Resistance among Streptococcus pyogenes Isolates in SpainJournal of Clinical Microbiology, 2002
- Variation in antibiotic use in the European UnionThe Lancet, 2001
- The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens.Journal of Antimicrobial Chemotherapy, 2001
- Comparison of antimicrobial resistance phenotypes and resistance genes in Enterococcus faecalis and Enterococcus faecium from humans in the community, broilers, and pigs in DenmarkDiagnostic Microbiology and Infectious Disease, 2000
- Streptococcus pyogenesCollected in Torino (Northwest Italy) Between 1983 and 1998: Survey of Macrolide Resistance and Trend of Genotype by RAPDMicrobial Drug Resistance, 2000
- Phenotypes and Genotypes of Erythromycin-Resistant Streptococcus pyogenes Strains in Italy and Heterogeneity of Inducibly Resistant StrainsAntimicrobial Agents and Chemotherapy, 1999
- Incidence of erythromycin resistance in Streptococcus pyogenes: a 10-year studyDiagnostic Microbiology and Infectious Disease, 1999